Cargando…
General Commentary: Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study
Autor principal: | Muche, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207524/ https://www.ncbi.nlm.nih.gov/pubmed/35733775 http://dx.doi.org/10.3389/fendo.2022.893735 |
Ejemplares similares
-
Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
por: Viggers, Rikke, et al.
Publicado: (2021) -
Diabetic Retinopathy May Indicate an Increased Risk of Cardiovascular Disease in Patients With Type 1 Diabetes—A Nested Case-Control Study in Brazil
por: Melo, Laura Gomes Nunes, et al.
Publicado: (2019) -
Commentary: Early Clinical Indicators of Addison's Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study
por: Brož, Jan, et al.
Publicado: (2019) -
The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023) -
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
por: Abrahamsen, Bo, et al.
Publicado: (2016)